Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice.
Insulin resistance, the key defect in type 2 diabetes (T2D), is associated with a low capacity to adapt fuel oxidation to fuel availability, i.e., metabolic inflexibility. This, in turn, contributes to a further damage of insulin signaling. Effectiveness of T2D treatment depends in large part on the...
Guardado en:
Autores principales: | Olga Horakova, Dasa Medrikova, Evert M van Schothorst, Annelies Bunschoten, Pavel Flachs, Vladimir Kus, Ondrej Kuda, Kristina Bardova, Petra Janovska, Michal Hensler, Martin Rossmeisl, Rui Wang-Sattler, Cornelia Prehn, Jerzy Adamski, Thomas Illig, Jaap Keijer, Jan Kopecky |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c369ad1fc064c589162e6d74ea2dcba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet.
por: Vladimir Kus, et al.
Publicado: (2011) -
Exploring the associations between transcript levels and fluxes in constraint-based models of metabolism
por: Neeraj Sinha, et al.
Publicado: (2021) -
Predicting the murine enterocyte metabolic response to diets that differ in lipid and carbohydrate composition
por: Neeraj Sinha, et al.
Publicado: (2017) -
Novel standardized method for extracellular flux analysis of oxidative and glycolytic metabolism in peripheral blood mononuclear cells
por: Joëlle J. E. Janssen, et al.
Publicado: (2021) -
European Medicines Agency (EMA) announces termination of Avandia (rosiglitazone usage in Europe)
por: Inna Igorevna Klefortova
Publicado: (2010)